MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

HealthDay 26 October at 03.43 PM

Nemolizumab Improves Symptoms in Prurigo Nodularis


Treatment efficacy seen in primary end points of itch response and Investigator's Global Assessment response


Recent Comments


  • avatar